Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) primarily prescribed for the treatment of obsessive-compulsive disorder (OCD) and depression. It functions by increasing serotonin levels in the brain, helping to improve mood and reduce anxiety symptoms. Unlike other antidepressants, Fluvoxamine is particularly effective in managing intrusive thoughts and compulsive behaviors. Maintaining high pharmaceutical purity of Fluvoxamine is essential to ensure its therapeutic efficacy, minimize adverse effects, and meet regulatory standards. Impurity profiling is crucial for identifying and controlling unwanted substances that may arise during manufacturing, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 4 of 4 products

Catalogue No : FLUV-OCL-001
CAS No : 54739-18-3
In Stock
Synonyms
2-[[[(1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethanamine (Z)-butenedioate
2-[[[(1E)-5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]ethanamine (Z)-butenedioate

Catalogue No : FLUV-OCL-002
CAS No : 88699-87-0
In Stock
Synonyms
(E)-5-(2-Acetamidoethoxyimino)-5-(4-(trifluoromethyl)phenyl)pentanoic acid
(E)-5-(2-Acetamidoethoxyimino)-5-(4-(trifluoromethyl)phenyl)pentanoic acid

Catalogue No : FLUV-OCL-003
CAS No : 61718-80-7
In Stock
Synonyms
5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one
5-Methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one

Catalogue No : FLUV-OCL-004
CAS No : 88699-84-7
In Stock
Synonyms
(E)-N-[5-Methoxy-1-[4-(trifluoromethyl)phenyl]-pentylidene]hydroxylamine
(E)-N-[5-Methoxy-1-[4-(trifluoromethyl)phenyl]-pentylidene]hydroxylamine